Indication
Upper Gastrointestinal Cancer
2 clinical trials
1 product
Product
NivolumabClinical trial
Patients With Upper Gastrointestinal Adenocarcinoma Enrolled in a Patient Support Program to Receive Nivolumab in the Metastatic Setting: Real-World Data From CanadaStatus: Completed, Estimated PCD: 2024-01-25
Clinical trial
Patients With Upper Gastrointestinal Cancer Enrolled in a Patient Support Program to Receive Nivolumab in the Adjuvant Setting: Real World Data From CanadaStatus: Completed, Estimated PCD: 2024-01-25